Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report
Kvols, L.K.; Eagan, R.T.; Myers, R.P.
Cancer Treatment Reports 61(2): 311-312
1977
ISSN/ISBN: 0361-5960 PMID: 326400 Document Number: 118170
Document emailed within 1 workday
Related Documents
Curry, S.L.; Blessing, J.A.; Disaia, P.J.; Soper, J.T.; Twiggs, L.B. 1989: A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study Obstetrics and Gynecology 73(3 Pt 1): 357-362Yamada, Y.; Fujiwara, H.; Somiya, S.; Fujikawa, S.; Kamiyama, Y.; Tamaki, M.; Kanaoka, T. 2018: Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(4): 187-192
Rahman, F.; Rahardjo, H.Erlianti.; Ariwicaksono, S.Cahyo.; Hafizar, H.; Sembiring, M.Gozali.Arif.; Andika, R.; Patandung, R.; Hidianingsih, S.; Hotasi, S.L. 2017: The Role of Docetaxel in Non-Castrate Resistant Metastatic Prostate Cancer: An Evidence-based Case Report Acta Medica Indonesiana 49(1): 74-78
Pinto, F.; Brescia, A.; Sacco, E.; Volpe, A.; Gardi, M.; Gulino, G.; Bassi, P. 2009: Disseminated intravascular coagulation secondary to metastatic prostate cancer: case report and review of the literature Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 81(4): 212-214
Rodríguez Duarte, C.; Mattout, J.; Moreira, O.; Jiménez, R. 2002: Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report Archivos espanoles de urologia 55(7): 785-791
Hogan, T.F.; Citrin, D.L.; Freeberg, B.L. 1981: A preliminary report of mitotane therapy of advanced renal and prostate cancer Cancer Treatment Reports 65(5-6): 539-540
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Sirikulchayanonta, S.; Jaovisidha, S.; Kongchareonsombat, W.; Sirikulchayanonta, V. 2014: Paget's disease of bone in ethnic Thai presented with urologic symptoms and misleading as metastatic prostate cancer: report of a case with a review of the literature Journal of the Medical Association of Thailand 97(6): 673-677
Kapustin, V.V.; Gromov, A.I.; Koshurnikov, D.S. 2012: Comparative evaluation of the efficiency of different magnetic resonance imaging procedures in the recognition of local recurrence of prostate cancer: preliminary results Vestnik Rentgenologii i Radiologii 5: 48-51
Ishida, R.; Hamatake, M.; Wasserman, R.A.; Nitiss, J.L.; Wang, J.C.; Andoh, T. 1995: DNA topoisomerase Ii is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae Cancer Research 55(11): 2299-2303
Iyibozkurt, A.C.; Akhan, S.E.; Topuz, S.; Citil, I.; Berkman, S. 2005: Laparoscopic evaluation of metastatic ovarian cancer: a case report European Journal of Gynaecological Oncology 26(1): 123-124
Yano, T.; Nakatani, K.; Watanabe, A.; Sawada, H.; Okumura, T.; Yamada, Y.; Nakano, H. 1990: A comparison of the growth rate between a subcutaneous and a metastatic liver tumor of an AFP-producing human gastric cancer line in nude mice: preliminary report Nihon Geka Gakkai Zasshi 91(6): 785
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Celebi, M.M.; Venable, D.D.; Nopajaroonsri, C.; Eastham, J.A. 1997: Prostate cancer metastatic only to the penis Southern Medical Journal 90(9): 959-961
Amsellem, D.; Ogiez, N.; Salomon, L.; Chopin, D.; Abbou, C.C.; Colombel, M. 1998: Does PSA of less than 20 ng/ml exclude the diagnosis of metastatic prostate cancer? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 1018-1021
Bosnjak, S.; Jelić, S. 2003: Supportive care in patients with metastatic prostate cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 8(2): 111-120
Debruyne, F.M.; Fernandez del Moral, P.; Geboers, A.D. 1988: LHRH-analogues therapy for metastatic prostate cancer Progress in Clinical and Biological Research 260: 27-39
Satoh, T.; Ishiyama, H. 2017: Current multidisciplinary approaches for metastatic prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 75(4): 620-625